Renalytix plc financial data

Symbol
RNLXY, RTNXF on OTC
Industry
Services-Medical Laboratories
Location
Finsgate, 5 7 Cranwood Street, London, United Kingdom
State of incorporation
DE
Fiscal year end
June 30
Former names
Renalytix AI plc (to 6/25/2021)
Latest financial report
10-Q - Q3 2024 - Nov 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 45 % -74.3%
Debt-to-equity -186 % -168%
Return On Equity 293 %
Return On Assets -342 % -135%
Operating Margin -1.05K % +22.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 166M shares +74.6%
Common Stock, Shares, Outstanding 166M shares +76.9%
Entity Public Float 24.7M USD -45%
Common Stock, Value, Issued 515K USD +77.6%
Weighted Average Number of Shares Outstanding, Basic 106M shares +11.5%
Weighted Average Number of Shares Outstanding, Diluted 106M shares +11.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.35M USD -18.7%
Cost of Revenue 2.05M USD -17.5%
General and Administrative Expense 17M USD -35.9%
Operating Income (Loss) -24.8M USD +37%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -28M USD +36%
Income Tax Expense (Benefit) 6K USD +500%
Net Income (Loss) Attributable to Parent -28M USD +36%
Earnings Per Share, Basic -0.24 USD/shares +52%
Earnings Per Share, Diluted -0.24 USD/shares +52%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 909K USD -93.5%
Accounts Receivable, after Allowance for Credit Loss, Current 902K USD -11%
Assets, Current 2.88M USD -82.5%
Property, Plant and Equipment, Net 202K USD -78.6%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 869K USD -10.8%
Assets 4.79M USD -75.5%
Accounts Payable, Current 1.75M USD -15.1%
Employee-related Liabilities, Current 259K USD -88.8%
Accrued Liabilities, Current 2.16M USD -52.7%
Liabilities, Current 12M USD -20.8%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 14K USD
Liabilities 16.1M USD -23.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.03M USD -52.2%
Retained Earnings (Accumulated Deficit) -217M USD -14.9%
Stockholders' Equity Attributable to Parent -11.3M USD -659%
Liabilities and Equity 4.79M USD -75.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.84M USD +59.6%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 23K USD
Common Stock, Shares Authorized 174M shares +69.5%
Common Stock, Shares, Issued 166M shares +76.9%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.77M USD +65.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 41.3M USD -36.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 55.4M USD +21.6%
Operating Lease, Liability 11.5K USD -91.8%
Depreciation 110K USD -63.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.3M USD -128%
Lessee, Operating Lease, Liability, to be Paid 11.6K USD -92.3%
Property, Plant and Equipment, Gross 515K USD -72.6%
Operating Lease, Liability, Current 11K USD -91.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.6K USD -91.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 100 USD -98.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 46M USD +21.8%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 44K USD -65.6%
Operating Leases, Future Minimum Payments, Due in Two Years 153K USD +84.3%
Amortization of Intangible Assets 50K USD 0%
Depreciation, Depletion and Amortization 60K USD -52.8%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 162K USD
Deferred Tax Assets, Net of Valuation Allowance 82K USD -81.9%
Share-based Payment Arrangement, Expense 1.44M USD -46.6%
Operating Leases, Future Minimum Payments, Due in Three Years 45K USD -45.8%
Operating Leases, Future Minimum Payments Due 360K USD +30%